TrialOncotarget2015

The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib.

Luca Faloppi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.